Obesity treatment includes bariatric surgery procedures [2] and, more recently, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for pharmacological management [3]. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.